FDA Clears Wandercraft’s Exoskeleton for Rehabilitation of Stroke Patients

Wandercraft intends to ship its first exoskeletons to the United States in the first quarter of this year, but has not named any early clients. Although it has just recently begun doing business in the nation, financial backer Quadrant Management believes Wandercraft will be able to “substantially grow” its activities over the next one to two years.